Mary Chi Michael BS

Mary Michael is an innovative and trailblazing senior leader in the healthcare industry. She has an unparalleled track record of success in developing and incubating novel business solutions across a diverse portfolio of healthcare arenas, including biopharmaceuticals, orphan disease, digital health, and technology alliance partnerships. Mary is currently the Vice President of Patient Advocacy and Stakeholder Management at Otsuka America Pharmaceutical, Inc. In this role, Mary has championed a vast array of first-in-company and first-in-industry initiatives.

While at Otsuka, Mary spearheaded the launch of the Global Council on Alzheimer’s Disease (GCAD). GCAD is a collection of preeminent opinion leaders across the sectors that influence the Alzheimer’s space, including science, medicine, and policy, but also caregiving, technology, finance, religion, and law. In its first three years, GCAD created a set of online resources for caregivers; it crafted an Alzheimer’s Patient Navigation Model and published this concept in multiple peer-reviewed journals; and it launched a year-long initiative to spur innovation for Alzheimer’s within the technology community. Mary partnered with AGE-Well to develop and host a Pitch Event to Disrupt AD through Technology at the 2016 AAIC meeting. Mary’s leadership of GCAD pillar projects were showcased at the 2016 Alzheimer’s Europe Congress with both a poster and oral presentation within the scientific programme. Mary also joined the Dementia Action Alliance Scientific Advisory Board in 2016.